These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23462137)

  • 1. Structural basis for vitamin D receptor agonism by novel non-secosteroidal ligands.
    Asano L; Ito I; Kuwabara N; Waku T; Yanagisawa J; Miyachi H; Shimizu T
    FEBS Lett; 2013 Apr; 587(7):957-63. PubMed ID: 23462137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin D nuclear receptor.
    Ciesielski F; Sato Y; Chebaro Y; Moras D; Dejaegere A; Rochel N
    J Med Chem; 2012 Oct; 55(19):8440-9. PubMed ID: 22957834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
    J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition.
    Fischer J; Wang TT; Kaldre D; Rochel N; Moras D; White JH; Gleason JL
    Chem Biol; 2012 Aug; 19(8):963-71. PubMed ID: 22921063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
    Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
    J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
    Peräkylä M; Molnár F; Carlberg C
    Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.
    Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C
    Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism.
    Nakabayashi M; Yamada S; Yoshimoto N; Tanaka T; Igarashi M; Ikura T; Ito N; Makishima M; Tokiwa H; DeLuca HF; Shimizu M
    J Med Chem; 2008 Sep; 51(17):5320-9. PubMed ID: 18710208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fluorines on nonsecosteroidal vitamin D receptor agonists.
    Kashiwagi H; Ohta M; Ono Y; Morikami K; Itoh S; Sato H; Takahashi T
    Bioorg Med Chem; 2013 Feb; 21(3):712-21. PubMed ID: 23266184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.
    Yamamoto K; Masuno H; Choi M; Nakashima K; Taga T; Ooizumi H; Umesono K; Sicinska W; VanHooke J; DeLuca HF; Yamada S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1467-72. PubMed ID: 10677485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.
    Ciesielski F; Rochel N; Moras D
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):235-42. PubMed ID: 17218092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
    Mizwicki MT; Bishop JE; Norman AW
    Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of triple bond and adamantane ring on the vitamin D side chain produced partial agonists for vitamin D receptor.
    Kudo T; Ishizawa M; Maekawa K; Nakabayashi M; Watarai Y; Uchida H; Tokiwa H; Ikura T; Ito N; Makishima M; Yamada S
    J Med Chem; 2014 May; 57(10):4073-87. PubMed ID: 24773565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
    Anami Y; Itoh T; Egawa D; Yoshimoto N; Yamamoto K
    J Med Chem; 2014 May; 57(10):4351-67. PubMed ID: 24742174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone.
    Kakuda S; Ishizuka S; Eguchi H; Mizwicki MT; Norman AW; Takimoto-Kamimura M
    Acta Crystallogr D Biol Crystallogr; 2010 Aug; 66(Pt 8):918-26. PubMed ID: 20693691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and X-ray crystallographic study of new nonsecosteroidal vitamin D receptor ligands.
    Demizu Y; Takahashi T; Kaneko F; Sato Y; Okuda H; Ochiai E; Horie K; Takagi K; Kakuda S; Takimoto-Kamimura M; Kurihara M
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6104-7. PubMed ID: 21889334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural development of non-secosteroidal vitamin D receptor (VDR) ligands without any asymmetric carbon.
    Misawa T; Tsuji G; Takahashi T; Ochiai E; Takagi KI; Horie K; Kakuda S; Takimoto-Kamimura M; Kurihara M; Demizu Y
    Bioorg Med Chem; 2018 Dec; 26(23-24):6146-6152. PubMed ID: 30446437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDX reveals unique fragment ligands for the vitamin D receptor.
    Carson MW; Zhang J; Chalmers MJ; Bocchinfuso WP; Holifield KD; Masquelin T; Stites RE; Stayrook KR; Griffin PR; Dodge JA
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3459-63. PubMed ID: 24974344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations.
    Vanhooke JL; Tadi BP; Benning MM; Plum LA; DeLuca HF
    Arch Biochem Biophys; 2007 Apr; 460(2):161-5. PubMed ID: 17227670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
    Choi M; Makishima M
    Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.